Grove Biopharma

Developer of AI-based drug modality platform for protein-based drugs

placeChicago, Illinois, United States calendar_todayFounded 2020 groups7 employees language grovebiopharma.com

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 9 times.

YearFilings
20231
20241
20251

Social engagement

Social engagement: 3.3K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Portal Innovations, Skydeck Capital, Walder Ventures, DCVC.

Investor typeCountShare
Venture capital542%
Private equity18%
Accelerator & incubator18%
Other / undisclosed542%

Recent activity

15 May 2026
Event
PEGS Conference
Coming soon